Nov 11, 2018
New Novartis study supports Entresto as foundational HFrEF therapy and in-hospital initiation in appropriate stabilized heart failure patients
Nov 02, 2018
Novartis data at ASH and SABCS show strength of pipeline and portfolio in hematology and oncology
Oct 29, 2018
Novartis wins esteemed Prix Galien Foundation Best Biotechnology Product Award for CAR-T cell therapy, Kymriah®
Oct 27, 2018
Two-year data for Novartis brolucizumab reaffirm superiority versus aflibercept in reducing retinal fluid in patients with nAMD
Oct 24, 2018
Eyevance Pharmaceuticals Executes Strategic Transaction
Oct 22, 2018
Novartis presents new Cosentyx® data demonstrating long-term response and safety in ankylosing spondylitis
Oct 09, 2018
Novartis analysis shows crizanlizumab (SEG101) increased the number of patients free of sickle cell pain crises vs placebo during SUSTAIN study
Oct 08, 2018
Novartis announces FDA filing acceptance of siponimod (BAF312), the first and only oral drug shown to delay disability progression in typical SPMS patients
Aug 24, 2018
Global Tuberculosis (TB) Drugs/Therapeutics Market, 2018-2025 - Key Players are J&J Services, Lupin, Pfizer, Novartis, Macleods Pharmaceuticals, and Otsuka Pharmaceutical
Jun 11, 2018
Inflammatory Skin Diseases Drug Development Pipeline Review, 2018: 17 Products in Development Featuring GlaxoSmithKline and Novartis
Jun 11, 2018
Global Ocular Cancer Drug Development Pipeline Review 2018: 35 Products in Active Development Featuring Novartis and Eli Lilly
Jun 11, 2018
REGENXBIO Receives $100 Million Accelerated License Payment Due to Acquisition of AveXis by Novartis
May 17, 2018
Novartis data at ASCO and EHA reinforce company's commitment to reimagining cancer
Mar 28, 2018
Tasigna Lawsuits Mount, as Plaintiff in Washington State Accuses Novartis of Failing to Warn that Leukemia Drug Had Been Linked to Atherosclerosis-Related Conditions, Bernstein Liebhard LLP Reports
Nov 01, 2017
Novartis presents data at ASH for patients with serious blood disorders like lymphoma, leukemia and sickle cell disease
Aug 11, 2017
Argentum Pharmaceuticals Succeeds in Starting Patent Cancellation Trial Against Novartis' GILENYA®
Jun 16, 2017
Stocks Under Scanner in the Drug Makers Space -- TherapeuticsMD, GlaxoSmithKline, Novartis, and Tonix Pharma